活化mTOR在类风湿关节炎CXCR3+记忆B细胞中的病理作用
研究比较31例正常人与86例RA患者外周血B细胞的mTOR磷酸化与趋化因子受体表达,发现RA患者CXCR3+记忆B细胞比例降低而mTOR磷酸化增强且与疾病活动度相关,体外实验显示mTOR活化促进IL-6产生与RANKL表达,TNF抑制剂治疗可提高CXCR3+记忆B细胞比例并降低血清CXCL10。
要点
- RA患者CXCR3+记忆B细胞中mTOR磷酸化选择性增强,且与疾病活动度相关
- mTOR活化通过促进IL-6产生和RANKL表达介导病理作用
- TNF抑制剂治疗可提高CXCR3+记忆B细胞比例并降低血清CXCL10
核心结论
- RA患者CXCR3+记忆B细胞中mTOR活化与疾病活动度相关,并通过IL-6产生和RANKL表达介导。
- 结果提示TNF抑制剂影响CXCL10与mTOR活化的CXCR3+记忆B细胞之间的关联。
研究设计与样本
- 研究纳入31例正常受试者与86例RA患者,分离外周血单个核细胞,检测B细胞mTOR磷酸化与趋化因子受体表达。
- 对来自对照与RA患者的外周血B细胞进行体外研究以探讨分子机制。
主要发现
- RA患者外周血CXCL10浓度高于对照,而CXCR3+记忆B细胞百分比较对照低。
- CXCL10浓度高的RA患者CXCR3+记忆B细胞百分比更小且疾病活动度高。
- TNF抑制剂治疗一年提高了CXCR3+记忆B细胞百分比并降低血清CXCL10浓度。
- RA患者B细胞mTOR磷酸化较对照进一步增强,并在CXCR3+记忆B细胞中选择性增强。
- 体外B细胞mTOR磷酸化增强IL-6产生并增加RANKL表达。
临床怎么用
- CXCR3+记忆B细胞mTOR磷酸化有望作为反映RA疾病活动度的指标。
- TNF抑制剂对CXCL10与mTOR活化CXCR3+记忆B细胞关联的影响值得在临床监测中关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: B cells play an important pathological role in RA. In this study, we investigated the role of metabolic regulator mTOR in B cells and its relevance to the pathology of RA. METHODS: Peripheral blood mononuclear cells were isolated from 31 normal subjects and 86 RA patients and the gated B cells were assessed for mTOR phosphorylation and chemokine receptor expression. In vitro studies on peripheral blood B cells isolated from the control and RA patients investigated the molecular mechanisms. RESULTS: Higher concentrations of CXCL10 (CXCR3 ligands) and lower percentages of CXCR3+ memory B cells were present in the peripheral blood of RA patients relative to the control. RA patients with high CXCL10 concentrations had smaller percentage of CXCR3+ memory B cells and high disease activity. One-year treatment with TNF inhibitors increased the percentage of CXCR3+ memory B cells and reduced serum CXCL10 concentrations. mTOR phosphorylation in B cells was further enhanced in RA patients, compared with the control, and was selectively enhanced in CXCR3+ memory B cells. mTOR phosphorylation in CXCR3+ memory B cells correlated with disease activity. In vitro, mTOR phosphorylation in B cells enhanced IL-6 production and increased RANKL expression. CONCLUSION: mTOR activation in CXCR3+ memory B cells of RA patients is associated with disease activity, mediated through IL-6 production and RANKL expression. The obtained results also suggest that TNF inhibitors mediate an impact on the association between CXCL10 and mTOR activated CXCR3+ memory B cells.
引用
- Iwata S, Zhang M, Hajime M, et al. Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis. Rheumatology (Oxford). 2021. PMID: 33693564. doi:10.1093/rheumatology/keab229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。